ArticleBioinformatics advances2026
CaRinDB: an integrated database of common cancer mutations and residue interaction network parameters.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Predicting the impact of missense mutations on protein structure and function is a fundamental challenge for cancer research and clinical applications. Despite all the computational advances and, more recently, the use of artificial intelligence (AI), assessing the functional consequences of residue substitutions remains a challenging task. Proteins have complex three-dimensional structures, where the maintenance of their functionality depends on chemical interactions between amino acid residues. Single substitutions can affect these interactions, leading to more profound structural changes that are difficult to visualize. Results: Here, we present CaRinDB, a database that integrates cancer-associated missense mutation data, functional predictions, molecular features, allelic frequencies, and residue interaction network (RIN) parameters derived from Protein Data Bank structures and AlphaFold models. Users can access and explore variant information through an intuitive web portal, with custom plots and tables to visualize and analyze cancer-associated mutation data. CaRinDB is the first database that unites distinct annotation features of cancer-associated mutations and their structural impacts, utilizing RINs graph parameters and a source of compiled and processed data for the development of AI tools. Availability and implementation: CaRinDB is freely available at https://bioinfo.imd.ufrn.br/CaRinDB/. The integrated development environment used was Jupyter notebooks, available on GitHub (https://github.com/evomol-lab/CaRinDB). CaRinDB web interface was implemented in R and Shiny.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.